Acute Coronary Syndromes

Science News

Dr. Jeremiah Stamler, 'the father of preventive cardiology,' dies at 102
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Public comment for the 2022 AHA ACC Key Data Elements and Definitions for Chest Pain and Acute MI
Impact of the COVID-19 Pandemic on Cardiovascular Science
2021 Guideline for the Evaluation and Diagnosis of Chest Pain

Journals

Ischemic ST‐Segment Depression Maximal in V1–V4 (Versus V5–V6) of Any Amplitude Is Specific for Occlusion Myocardial Infarction (Versus Nonocclusive Ischemia)
How Many Operators Are Optimal for Higher‐Risk Percutaneous Coronary Intervention Procedures?
Clinical Characteristics and Outcomes Among Patients Undergoing High‐Risk Percutaneous Coronary Interventions by Single or Multiple Operators: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program
Macrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the Effect of CD47 Blockade on Efferocytosis and Atherogenesis
Letter by Schaefer et al Regarding Article, “Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US Cohort”

Continuing Education

Scientific Sessions attendees looking at a phone in front of giant Heart and Torch stature

Meet us in November in Boston or online from anywhere through our virtual platform for the global cardiovascular event of the year! Reconnect with colleagues, experience breakthrough cardiovascular basic, clinical and population science updates, and immerse yourself in innovative solutions designed to help you in your daily practice at the American Heart Association’s Scientific Sessions 2021.

  • Enjoy instant access to leaders in the field and the latest discoveries in cardiovascular science and medicine.

  • Reconnect and collaborate with global thought leaders from over around the world.

  • Experience programming designed with your needs in mind with 27 programming communities.
  • CE and MOC credits available.

  • And more!

Don’t forget! AHA Professional Members receive the best rates for attending Scientific Sessions. Learn more about this and other benefits by becoming an AHA Professional Member.

The 3CPR Council’s areas of focus encompass integrated cardiopulmonary physiology, critical care, emergency cardiovascular care, and CPR. The council takes a bench-to-bedside and community approach to clinical care, research, and basic science. Pulmonary hypertension and regulation of pulmonary circulation have been topics of ongoing attention.


The CVSN Council accelerates the discovery, interpretation, and application of science to enhance cardiovascular health and treat cardiovascular diseases and stroke. The council helps develop scientific statements and advisories, guide professional education activities, provide scientific expertise, conduct research, translate findings, and promote evidence-based practices in clinical settings.


The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.


The CVSA Council includes surgeons, anesthesiologists and scientists interested in cardiac, vascular, and thoracic interventions. Involved in basic science and clinical trials, the council seeks to increase awareness of important issues in cardiovascular surgery and anesthesia, disseminate new knowledge, and encourage use of optimal surgical procedures and anesthetic techniques.


The CVRI Council’s mission is to provide leadership to the AHA to reduce death and disability from cardiovascular, peripheral vascular, and cerebrovascular diseases, using diagnostic and functional imaging and imaging-directed interventions. Council members work to provide outstanding research, education, outreach, and mentorship opportunities.


STRENGTH Results

Principal investigator A. Michael Lincoff, MD summarizes the results of the STRENGTH Trial, which looked at the effects of omega-3 carboxylic acid on clinical outcomes in patients at high cardiovascular risk.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses